Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth

Vancouver, British Columbia--(. - September 3, 2026) - Restart Life Sciences Corp. CSE:HEAL (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce its financial and operating results for the three and six months ended June 30, 2026. All financial figures…